← Open Payments lookup

KURTIS KLECAN: Open Payments

NPI 1154854008 · BELLEVILLE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$526 in 28 payments from 13 companies in 2025. Trend: 2023 $465 · 2024 $636 · 2025 $526

Food & beverage: $526
CompanyPaymentsAmount
Paratek Pharmaceuticals, Inc.6$103
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$63
Otsuka America Pharmaceutical, Inc.2$58
Viatris Specialty LLC3$45
ABBVIE INC.2$43
Xeris Pharmaceuticals, Inc.2$38
Bayer Healthcare Pharmaceuticals Inc.2$38
Novo Nordisk Inc2$32
AstraZeneca Pharmaceuticals LP2$31
Supernus Pharmaceuticals, Inc.1$24

Products named: NUZYRA, CAPLYTA, REXULTI, YUPELRI, KEVEYIS, Kerendia, AIRSUPRA, Qelbree.

Industry payments across KS — which companies pay providers there.